24 |
ASSIST: Early Eptifibatide Administration in Patients with AMI Undergoing Primary PCI After Thienopyridine Loading |
Michel Le May |
Dec. 09. 08 |
23 |
NAPLES: Bivalirudin vs. Unfractionated Heparin plus Tirofiban in Patients with Diabetes Undergoing Elective PCI |
Carlo Briguori |
Dec. 09. 08 |
22 |
ARNO: Bivalirudin vs. Unfractionated Heparin plus Protamine in Patients Undergoing Elective PCI |
David Antoniucci |
Dec. 09. 08 |
21 |
HORIZONS AMI AMI: Prospective Randomized Trials of Paclitaxel-Eluting Stents vs. BMS in Patients with STEMI |
Gregg W. Stone |
Dec. 09. 08 |
20 |
Triple Antiplatelet Therapy After DES Implantation in Patients with High Risk of Restenosis |
Seong-Wook Park |
Oct. 24. 08 |
19 |
Is Triple Anti-Platelet Therapy a Solution for Patients with Aspirin/Plavix Resistance ? |
Jung-Won Suh |
Oct. 24. 08 |
18 |
How Long Patients Will Be on Dual Antiplatelet Therapy? |
Ron Waksman |
Oct. 24. 08 |
17 |
Insights into Antiplatelet Therapy: From CAPRIE to TRITON-TIMI 38 |
Cheol Whan Lee |
Oct. 24. 08 |
16 |
Triple Antiplatelet Therapy Significantly Reduced Stent Thrombosis After Drug-Eluting Stent Implantation |
Seong-Wook Park |
Jul. 18. 08 |
15 |
Optimizing Antiplatelet Therapy in PCI/ Antiplatelet Therapy After PCI: How Much and How Long? |
Adnan Kastrati |
Jul. 18. 08 |